South Africa halts use of J&J vaccine over blood clot fears

South Africa suspended giving Johnson & Johnson vaccine shots Tuesday as a “precautionary measure” and the company delayed its European vaccine rollout following the FDA decision to pause using the jabs while blood clot cases are examined.
DRC received 1.7 million jabs and was due to roll out on March 15
DR Congo postpones AstraZeneca vaccine rollout over blood clot fears
The DR Congo will postpone its vaccination campaign using the AstraZeneca jab, following other countries taking similar precautionary measures, the government said on Saturday.
Egypt has so far okayed three vaccines; Sinopharm, AstraZeneca, Sputnik V
Egypt begins vaccine rollout to wider population
Egypt on Thursday expanded its coronavirus vaccination rollout to include the elderly and people with chronic diseases after several weeks of vaccinating medical staff, the cabinet said.
COVAX is a WHO-backed equitable vaccine distribution network
Ivory Coast becomes second country to receive COVAX vaccines
Ivory Coast received a shipment of COVID-19 doses from the COVAX vaccine-sharing facility on Friday, becoming the second country to benefit from a programme meant to ensure fairer distribution amid a global scramble.
COVAX is a WHO-backed equitable vaccine distribution network
Global reactions as Ghana receives historic COVAX consignment
Ghana’s receipt today, February 24, 2021, of a coronavirus vaccine consignment has been hailed across the continent and beyond.
File photo: A special flight carrying the Merck vaccine landed in Guinea on Monday, February 23
Guinea readies for Ebola vaccination
Guinea will launch an Ebola vaccination drive Tuesday after a flight delayed by a Saharan dust storm arrived carrying thousands of jabs, as the West African country fights to stamp out a resurgence of the deadly virus.
The AVATT team that secured the doses was set up by the African Union
Africa CDC secures 300 million doses of Russia's Sputnik V vaccine
The AVATT team had earlier on secured over 270 million doses of AstraZeneca, Pfizer, and Johnson & Johnson vaccines in the first allocation phase.